PLSE Fundamental Analysis - PULSE BIOSCIENCES INC

Fundamental Rating

PLSE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for PLSE as it has an excellent financial health rating, but there are worries on the profitability. PLSE does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

PLSE had negative earnings in the past year.

PLSE had a negative operating cash flow in the past year.

PLSE had negative earnings in each of the past 5 years.

PLSE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

PLSE has a Return On Assets of -45.17%. This is in the lower half of the industry: PLSE underperforms 65.96% of its industry peers.

With a Return On Equity value of -50.86%, PLSE perfoms like the industry average, outperforming 47.87% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-45.17%
ROE	-50.86%
ROIC	N/A

ROA(3y)-62.31%

ROA(5y)-85%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

PLSE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for PLSE has been increased compared to 1 year ago.

The number of shares outstanding for PLSE has been increased compared to 5 years ago.

There is no outstanding debt for PLSE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 41.99 indicates that PLSE is not in any danger for bankruptcy at the moment.

PLSE has a Altman-Z score of 41.99. This is amongst the best in the industry. PLSE outperforms 99.47% of its industry peers.

PLSE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	41.99

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 15.58 indicates that PLSE has no problem at all paying its short term obligations.

PLSE has a Current ratio of 15.58. This is amongst the best in the industry. PLSE outperforms 95.74% of its industry peers.

A Quick Ratio of 15.58 indicates that PLSE has no problem at all paying its short term obligations.

PLSE has a better Quick ratio (15.58) than 97.34% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	15.58
Quick Ratio	15.58

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for PLSE have decreased strongly by -19.63% in the last year.

EPS 1Y (TTM)-19.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-21.43%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PLSE. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

PLSE does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PULSE BIOSCIENCES INC

NASDAQ:PLSE (6/2/2025, 4:30:01 PM)

After market: 16.88 0 (0%)

16.88

-0.43 (-2.46%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)05-08 2025-05-08/amc

Earnings (Next)08-11 2025-08-11

Inst Owners9.9%

Inst Owner Change-4.49%

Ins Owners79.48%

Ins Owner Change10.23%

Market Cap1.14B

Analysts43.33

Price TargetN/A

Short Float %13.62%

Short Ratio12.24

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	9.59
P/tB	9.91
EV/EBITDA	N/A

EPS(TTM)-0.97

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.6

FCFYN/A

OCF(TTM)-0.6

OCFYN/A

SpS0

BVpS1.76

TBVpS1.7

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-45.17%
ROE	-50.86%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-62.31%

ROA(5y)-85%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	14.2%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	15.58
Quick Ratio	15.58
Altman-Z	41.99

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)16.68%

Cap/Depr(5y)25.66%

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-19.63%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-21.43%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-38.45%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-5.5%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-5.51%

OCF growth 3YN/A

OCF growth 5YN/A

PULSE BIOSCIENCES INC (PLSE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens